Sonoma Pharmaceuticals, Inc. (SNOA) Financials

$2.75

north_east $0.02 (0.73%)
Day's range
$2.67
Day's range
$2.79

SNOA Income statement / Annual

Last year (2024), Sonoma Pharmaceuticals, Inc.'s total revenue was $12.74 M, a decrease of 4.05% from the previous year. In 2024, Sonoma Pharmaceuticals, Inc.'s net income was -$4.84 M. See Sonoma Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 03/31/2024 03/31/2023 03/31/2022 03/31/2021 03/31/2020 03/31/2019 03/31/2018 03/31/2017 03/31/2016 03/31/2015
Operating Revenue $12.74 M $13.27 M $12.63 M $18.63 M $18.94 M $18.97 M $16.66 M $12.83 M $15.08 M $13.85 M
Cost of Revenue $7.99 M $8.80 M $8.64 M $12.07 M $10.60 M $10.09 M $9.35 M $7.16 M $7.87 M $6.57 M
Gross Profit $4.75 M $4.48 M $3.99 M $6.56 M $8.33 M $8.88 M $7.31 M $5.67 M $7.21 M $7.29 M
Gross Profit Ratio 0.37 0.34 0.32 0.35 0.44 0.47 0.44 0.44 0.48 0.53
Research and Development Expenses $1.87 M $207,000.00 $125,000.00 $555,000.00 $1.34 M $1.52 M $1.58 M $1.58 M $1.81 M $1.53 M
General & Administrative Expenses $7.42 M $8.68 M $9.67 M $9.41 M $13.63 M $18.62 M $19.92 M $17.07 M $15.56 M $12.41 M
Selling & Marketing Expenses $156,000.00 $156,000.00 $86,000.00 $41,000.00 $35,000.00 $157,000.00 $177,000.00 $149,000.00 $175,000.00 $231,000.00
Selling, General & Administrative Expenses $7.58 M $8.84 M $9.76 M $9.45 M $13.67 M $18.62 M $19.92 M $17.07 M $15.56 M $12.41 M
Other Expenses $0.00 -$631,000.00 -$394,000.00 -$594,000.00 $240,000.00 -$239,000.00 -$357,000.00 $0.00 $0.00 $0.00
Operating Expenses $9.45 M $9.05 M $9.88 M $10.01 M $15.00 M $20.14 M $21.50 M $18.64 M $17.36 M $13.95 M
Cost And Expenses $17.44 M $17.84 M $18.52 M $22.08 M $25.61 M $30.23 M $30.85 M $25.80 M $25.24 M $20.51 M
Interest Income $0.00 $16,000.00 $10,000.00 $16,000.00 $50,000.00 $190,000.00 $258,000.00 $22,000.00 $2,000.00 $1,000.00
Interest Expense $0.00 $16,000.00 $10,000.00 $12,000.00 $16,000.00 $33,000.00 $40,000.00 $3,000.00 $3,000.00 $3,000.00
Depreciation & Amortization $176,000.00 $298,000.00 $409,000.00 $227,000.00 $312,000.00 $453,000.00 $490,000.00 $248,000.00 $244,000.00 $253,000.00
EBITDA -$4.53 M -$4.45 M -$5.70 M -$3.22 M -$3.22 M -$10.85 M -$13.80 M -$12.69 M -$14.48 M -$7.95 M
EBITDA Ratio -0.36 -0.33 -0.52 -0.2 -0.32 -0.57 -0.86 -1.01 -0.67 -0.48
Operating Income Ratio -0.37 -0.34 -0.47 -0.19 -0.35 -0.59 -0.85 -1.01 -0.67 -0.48
Total Other Income/Expenses Net -$330,000.00 -$614,000.00 $469,000.00 -$453,000.00 $3.85 M -$82,000.00 -$139,000.00 $37,000.00 -$10,000.00 -$1.54 M
Income Before Tax -$5.03 M -$5.18 M -$5.42 M -$3.90 M -$2.83 M -$11.34 M -$14.33 M -$12.94 M -$10.16 M -$8.20 M
Income Before Tax Ratio -0.4 -0.39 -0.43 -0.21 -0.15 -0.6 -0.86 -1.01 -0.67 -0.59
Income Tax Expense -$196,000.00 -$33,000.00 -$332,000.00 $713,000.00 $121,000.00 $458,000.00 -$807,000.00 -$4.27 M -$241,000.00 -$250,000.00
Net Income -$4.84 M -$5.15 M -$5.09 M -$4.62 M -$2.95 M -$11.80 M -$14.33 M $9.27 M -$10.16 M -$8.20 M
Net Income Ratio -0.38 -0.39 -0.4 -0.25 -0.16 -0.62 -0.86 0.72 -0.67 -0.59
EPS -10.64 -30.4 -38.4 -46.2 -39.8 -255.4 -569.8 390.6 -556.2 -764.4
EPS Diluted -10.64 -30.4 -38.4 -46.2 -39.8 -255.4 -569.4 390.6 -556.2 -764.4
Weighted Average Shares Out $454,500.00 $169,700.00 $132,650.00 $99,800.00 $73,850.00 $46,199.00 $25,150.00 $23,466.00 $18,272.00 $10,729.00
Weighted Average Shares Out Diluted $454,500.00 $169,700.00 $132,650.00 $99,800.00 $73,850.00 $46,200.00 $25,166.00 $23,722.00 $18,272.00 $10,729.00
Link